What are the recommended dosages of antiviral medications for an adult with herpes simplex virus epithelial keratitis?

HSV Epithelial Keratitis Antiviral Dosing

For HSV epithelial keratitis in adults, use combination therapy with topical ganciclovir 0.15% gel 3-5 times daily PLUS oral valacyclovir 500 mg 2-3 times daily or acyclovir 200-400 mg 5 times daily for acute treatment. 1

Topical Antiviral Options

Preferred topical agent:

• Ganciclovir 0.15% gel: 3-5 times daily 1, 2, 1
  • Less toxic to the ocular surface than trifluridine
  • Can be used for longer duration without significant epithelial toxicity

Alternative topical agent:

• Trifluridine 1% solution: 5-8 times daily 1, 2, 1
  • Critical caveat: Inevitably causes epithelial toxicity if used >2 weeks 1, 2, 1
  • Should be reserved for cases where ganciclovir is unavailable or ineffective

Oral Antiviral Options (Choose One)

The 2024 Ophthalmology guidelines provide three equivalent oral options 1:

• Acyclovir: 200-400 mg five times daily
• Valacyclovir: 500 mg two or three times daily
• Famciclovir: 250 mg twice daily

Treatment Strategy

Combination therapy is essential: Oral antivirals alone may not adequately prevent progression of HSV blepharoconjunctivitis, but adding topical antiviral treatment has proven effective 1. This dual approach addresses both active corneal infection and systemic viral replication.

Treatment Duration & Monitoring

• Continue treatment until complete epithelial healing
• Follow-up within 1 week with interval history, visual acuity measurement, and slit-lamp biomicroscopy 1, 2, 1
• For moderate to severe gingivostomatitis or extensive disease, consider starting with IV acyclovir 5-10 mg/kg three times daily, then transitioning to oral therapy once lesions begin regressing 3

Critical Management Pitfalls

Avoid topical corticosteroids: They potentiate HSV epithelial infections and are contraindicated in active epithelial disease 1, 2, 1. Steroids should only be considered for stromal keratitis, and only when combined with antiviral coverage.

Watch for epithelial toxicity: If using trifluridine beyond 2 weeks, switch to ganciclovir gel to prevent iatrogenic epithelial damage 1, 2, 1.

Resistant or Refractory Cases

If conventional therapy fails after 4-6 months:

• Consider oral valganciclovir 900 mg twice daily for 10 days as treatment dose 4
• Higher doses of oral antivirals may be effective in apparent resistance 1
• Perform epithelial debridement to allow genotypic/phenotypic testing for true antiviral resistance 5
• For proven acyclovir resistance, topical alternatives include foscarnet 1.2-1.4% or cidofovir 0.2-0.5% 5

Long-Term Prophylaxis

After acute episode resolution, use lower doses for recurrence prevention 1, 2, 1:

• Acyclovir 400 mg twice daily, or
• Valacyclovir 500 mg once or twice daily

Renal function monitoring: Exercise caution with all systemic antivirals in patients with impaired renal clearance—dose adjustment is mandatory 1.